{"content":"<li class=\"n-box-item date-title\" data-end=\"1488862799\" data-start=\"1488776400\" data-txt=\"Sunday, December 22, 2019\">Monday, March  6, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3248996\" data-ts=\"1488847908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIT\" target=\"_blank\">FIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248996-fitbit-announces-leadership-changes-business-alignment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fitbit announces leadership changes, business alignment</a></h4><ul>    <li>Fitbit (<a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a> <font color='red'>-1.2%</font>) has announced <a href=\"https://seekingalpha.com/pr/16762732-fitbit-announces-changes-leadership-team\" target=\"_blank\">changes to its leadership team</a>, including a pair of executive departures, and a business realignment.</li>    <li>Chief Business Officer Woody Scal and Executive VP, Interactive Tim Roberts -- two of the company's first employees -- will depart the company by the end of the month.</li>    <li>VP of Engineering Samir Kapoor is being promoted to senior VP of Device Engineering, reporting to the company's CTO and co-founder Eric Friedman.</li>    <li>The company says it's formally realigning around two focus areas:  Consumer Health and Fitness; and Enterprise Health.</li>    <li>Consumer Health and Fitness will focus on delivering a streamlined set of health and fitness devices, entering new markets such as the smartwatch category and offering premium software and services that provide more personalized insights and guidance,\" the company says. \"Enterprise Health will expand on the company&rsquo;s early successes in working with insurance companies, employers, health systems and other healthcare partners.</li>    <li>After hours: <a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a> <font color='green'>+1.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248996\" data-linked=\"Fitbit announces leadership changes, business alignment\" data-tweet=\"$FIT - Fitbit announces leadership changes, business alignment https://seekingalpha.com/news/3248996-fitbit-announces-leadership-changes-business-alignment?source=tweet\" data-url=\"https://seekingalpha.com/news/3248996-fitbit-announces-leadership-changes-business-alignment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248988\" data-ts=\"1488844078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SALE\" target=\"_blank\">SALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248988-retailmenot-ir-development-head-moves-to-contractor-status\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RetailMeNot IR/development head moves to contractor status</a></h4><ul>   <li>RetailMeNot (<a href='https://seekingalpha.com/symbol/SALE' title='RetailMeNot, Inc.'>SALE</a> <font color='red'>-2.3%</font>) notes in a <a href=\"https://seekingalpha.com/filing/3447250\" target=\"_blank\">filing</a> that its senior VP, Corporate Development and Investor Relations resigned his position.</li>    <li>It's entered into a contractor agreement with Michael Magaro to provide some investor relations and corporate development services to the company instead.</li>    <li>The agreement filed with the SEC is a deal running from April 1, 2017, to May 15, 2017, for a fixed fee of $96,666 plus expenses.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248988\" data-linked=\"RetailMeNot IR/development head moves to contractor status\" data-tweet=\"$SALE - RetailMeNot IR/development head moves to contractor status https://seekingalpha.com/news/3248988-retailmenot-ir-development-head-moves-to-contractor-status?source=tweet\" data-url=\"https://seekingalpha.com/news/3248988-retailmenot-ir-development-head-moves-to-contractor-status\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248987\" data-ts=\"1488842984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFT\" target=\"_blank\">WFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248987-weatherford-snags-halliburton-cfo-mccollum-new-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weatherford snags Halliburton CFO McCollum as its new CEO</a></h4><ul>     <li>Weatherford (NYSE:<a href='https://seekingalpha.com/symbol/WFT' title='Weatherford International Ltd.'>WFT</a>) <font color='green'>+10.3%</font>&nbsp;AH after appointing Halliburton (NYSE:<a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a>)&nbsp;CFO Mark McCollum as its <a href=\"https://seekingalpha.com/pr/16762772-weatherford-appoints-mark-mccollum-president-ceo-director\" target=\"_blank\">new President and CEO</a>, effective in late April.</li>     <li>McCollum 36 years' experience in the energy sector includes two periods as HAL's CFO during 2008-14 and July 2016 to the present, as well as an interim role as Chief Integration Officer during HAL's proposed acquisition of Baker Hughes; previously, he had held various senior positions at Tenneco, including CFO, and at Arthur Andersen.</li>     <li>Krishna Shivram will depart as interim CEO, effective immediately; WFT&nbsp;CFO Christoph Bausch will serve as acting CEO until McCollum assumes the role in a permanent  capacity.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3248987\" data-linked=\"Weatherford snags Halliburton CFO McCollum as its new CEO\" data-tweet=\"$WFT $WFTIQ $HAL - Weatherford snags Halliburton CFO McCollum as its new CEO https://seekingalpha.com/news/3248987-weatherford-snags-halliburton-cfo-mccollum-new-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3248987-weatherford-snags-halliburton-cfo-mccollum-new-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248984\" data-ts=\"1488842126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MEET\" target=\"_blank\">MEET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248984-meetmeplus-19_3-q4-2016-positive-acquired\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MeetMe +19.3%; Q4 2016 positive, if(we) acquired</a></h4><ul><li><strong>Q4 2016 results</strong> &ndash; revenue $29.2M (+46.9% Y/Y,&nbsp;<font color='green'>$0.45M above estimates</font>), EPS $0.19 (<font color='green'>$0.03 above estimates</font>), Mobile revenue $27.8M (+62% Y/Y), net income $12.4M (+56% Y/Y), adjusted EBITDA $12.8M (+42% Y/Y), cash and cash equivalents $21.9M</li><li><strong>Other developments</strong> &ndash; <a href=\"http://www.snl.com/Cache/1500096659.PDF?Y=&amp;O=PDF&amp;D=&amp;fid=1500096659&amp;T=&amp;iid=4392695\" target=\"_blank\">Acquires if(we)</a> for $60M in cash.</li><li><strong>After hours</strong> &ndash; (NASDAQ:<a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a>) $6.05</li><li><a href=\"https://seekingalpha.com/pr/16762595-meetme-reports-record-revenue-net-income-adjusted-ebitda-fourth-quarter-full-year-2016\" target=\"_blank\">Press release</a> / <a href=\"https://streaming.webcasts.com/starthere.jsp?ei=1137392\" target=\"_blank\">conference call</a> / <a href=\"http://www.snl.com/Cache/1500096657.PDF?Y=&amp;O=PDF&amp;D=&amp;FID=1500096657&amp;T=&amp;IID=4392695\" target=\"_blank\">presentation slides</a> /&nbsp;<a href=\"https://seekingalpha.com/filing/3447564\" target=\"_blank\">8-K</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3248984\" data-linked=\"MeetMe +19.3%; Q4 2016 positive, if(we) acquired\" data-tweet=\"$MEET - MeetMe +19.3%; Q4 2016 positive, if(we) acquired https://seekingalpha.com/news/3248984-meetmeplus-19_3-q4-2016-positive-acquired?source=tweet\" data-url=\"https://seekingalpha.com/news/3248984-meetmeplus-19_3-q4-2016-positive-acquired\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248980\" data-ts=\"1488840436\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DISH\" target=\"_blank\">DISH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248980-dish-network-joining-s-and-p-500-shares-up-5_1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dish Network joining S&amp;P 500; shares up 5.1%</a></h4><ul>   <li>Dish Network (NASDAQ:<a href='https://seekingalpha.com/symbol/DISH' title='DISH Network Corporation'>DISH</a>) is <font color='green'>up 5.1%</font> after hours on news that it will <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/493956_lineardish5.pdf?force_download=true\" target=\"_blank\">enter the S&amp;P 500</a>.</li>    <li>The stock is making the move before Monday's open. It will replace Linear Technology, set to be acquired by Analog Devices in a deal about to close.</li>    <li>Dish Network will join the 500's Cable &amp; Satellite Sub-Industry Index.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248980\" data-linked=\"Dish Network joining S&amp;P 500; shares up 5.1%\" data-tweet=\"$DISH - Dish Network joining S&amp;P 500; shares up 5.1% https://seekingalpha.com/news/3248980-dish-network-joining-s-and-p-500-shares-up-5_1?source=tweet\" data-url=\"https://seekingalpha.com/news/3248980-dish-network-joining-s-and-p-500-shares-up-5_1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248979\" data-ts=\"1488840192\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248979-ibm-salesforce-form-global-strategic-partnership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM, Salesforce form global strategic partnership</a></h4><ul><li><a href=\"https://www.ibm.com/watson/\" target=\"_blank\">IBM Watson</a>&nbsp;and <a href=\"https://www.salesforce.com/products/einstein/overview/\" target=\"_blank\">Salesforce Eintstein</a>&nbsp;are&nbsp;<a href=\"https://seekingalpha.com/pr/16762645-ibm-salesforce-announce-landmark-global-strategic-partnership\" target=\"_blank\">integrating</a>&nbsp;in effort to enhance customer engagement among sales, service, commerce, marketing and other areas.</li><li>Additionally, IBM initiates strategic investment in its Global Business Services features for Salesforce, with new function of aiding deployment of merged IBM Watson and Salesforce Einstein capabilities to be added.</li><li>Component of the arrangement, IBM will internally deploy Salesforce Service Cloud.</li><li>Salesforce (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='Salesforce.com, Inc.'>CRM</a>)&nbsp;<font color='green'>+2.12%</font>, IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>)&nbsp;<font color='green'>+0.09%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248979\" data-linked=\"IBM, Salesforce form global strategic partnership\" data-tweet=\"$CRM $CRM $IBM - IBM, Salesforce form global strategic partnership https://seekingalpha.com/news/3248979-ibm-salesforce-form-global-strategic-partnership?source=tweet\" data-url=\"https://seekingalpha.com/news/3248979-ibm-salesforce-form-global-strategic-partnership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248978\" data-ts=\"1488839752\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248978-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='green'>+5.3%</font>. <a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports Inc.'>PIR</a> <font color='green'>+5.1%</font>. <a href='https://seekingalpha.com/symbol/DISH' title='DISH Network Corporation'>DISH</a> <font color='green'>+4.6%</font>. <a href='https://seekingalpha.com/symbol/ATSG' title='Air Transport Services Group, Inc'>ATSG</a> <font color='green'>+3.6%</font>. <a href='https://seekingalpha.com/symbol/WMC' title='Western Asset Mortgage Capital Corporation'>WMC</a> <font color='green'>+2.8%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a> <font color='red'>-5.2%</font>. <a href='https://seekingalpha.com/symbol/CASY' title='Casey&#39;s General Stores, Inc.'>CASY</a> <font color='red'>-3.9%</font>. <a href='https://seekingalpha.com/symbol/HASI' title='Hannon Armstrong Sustainable Infrastructure Capital'>HASI</a> <font color='red'>-3.6%</font>. <a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a> <font color='red'>-2.9%</font>. <a href='https://seekingalpha.com/symbol/JPEP' title='JP Energy Partners LP'>JPEP</a> <font color='red'>-2.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248978\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$ASNA $PIR $DISH - After Hours Gainers / Losers https://seekingalpha.com/news/3248978-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3248978-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248967\" data-ts=\"1488837674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDT\" target=\"_blank\">IDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248967-revenues-profits-drop-in-idts-second-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Revenues, profits drop in IDT&#39;s second quarter</a></h4><ul>   <li>IDT (<a href='https://seekingalpha.com/symbol/IDT' title='IDT Corporation'>IDT</a> <font color='red'>-4.1%</font>) is flat after hours following <a href=\"https://seekingalpha.com/news/3248952-idt-corporation-reports-fq2-results\" target=\"_blank\">fiscal second quarter earnings</a> where profits slipped along with revenues, though the company pointed to momentum in products that will drive forward growth.</li>    <li>\"We introduced the BOSS Revolution Money app including our flagship international money transfer service and released a major update of the BOSS Revolution calling app including messaging and free peer-to-peer calling,\" says CEO Shmuel Jonas, noting the two apps now work in tandem for convenience.</li>    <li>Meanwhile, National Retail Solutions has increased customers for its POS terminals tenfold, and net2phone quadrupled its customer base over the past year.</li>    <li>The company partly offset a revenue decline of 3.9% by cutting costs (SG&amp;A expense was down 7.3%).</li>    <li>Revenue by segment: TPS, $358.5M (down 3.3%); UCaaS, $7.1M (up 16.4%); CPS, $1.4M (down 22.2%); other, $0.5M (down 87.5%).</li>    <li><a href=\"http://www.idt.net/ir\" target=\"_blank\">Conference call</a> to come at 5:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16762683-idt-corporation-reports-second-quarter-fiscal-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3248967\" data-linked=\"Revenues, profits drop in IDT&#39;s second quarter\" data-tweet=\"$IDT - Revenues, profits drop in IDT&#39;s second quarter https://seekingalpha.com/news/3248967-revenues-profits-drop-in-idts-second-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3248967-revenues-profits-drop-in-idts-second-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248950\" data-ts=\"1488835859\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248950-snap-closes-below-ipo-open-amid-expanding-negative-sentiment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap closes below IPO open amid expanding negative sentiment</a></h4><ul><li>With&nbsp;scrutiny sustaining over valuation, <a href=\"http://www.reuters.com/article/us-snap-ipo-indexes-idUSKBN16D2D6\" target=\"_blank\">corporate governance</a>, and various business risk factors, combined with the&nbsp;<a href=\"https://www.bloomberg.com/news/articles/2017-03-06/snap-tumbles-for-first-time-since-ipo-as-analysts-say-sell\" target=\"_blank\">absence</a>&nbsp;of any buy-equivalent sell-side ratings (and a&nbsp;<a href=\"https://seekingalpha.com/news/3248748-snap-gets-barrons-treatment-another-sell-side-sell-call-still-4-percent-premarket\" target=\"_blank\">growing</a>&nbsp;list of negative and neutral standpoints),&nbsp;Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) shares have reduced to $23.50 and below in extended Monday trade, marking the lowest levels (IPO open $24, offer $17)&nbsp;since public share availability began last Thursday.</li><li>Previously &ndash;&nbsp;<a href=\"https://seekingalpha.com/news/3248279-nomura-pivotal-research-negative-snap-amid-trading-debut\" target=\"_blank\">Nomura, Pivotal Research negative on Snap amid trading debut</a> (March 2) /&nbsp;<a href=\"https://seekingalpha.com/news/3248506-susquehanna-initiates-snap-neutral-22-target\" target=\"_blank\">Susquehanna initiates Snap at Neutral, $22 target</a> (March 3) /&nbsp;<a href=\"https://seekingalpha.com/news/3248599-snap-downgraded-underweight-atlantic-equities\" target=\"_blank\">Snap downgraded to Underweight at Atlantic Equities</a> (March 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3248950\" data-linked=\"Snap closes below IPO open amid expanding negative sentiment\" data-tweet=\"$SNAP - Snap closes below IPO open amid expanding negative sentiment https://seekingalpha.com/news/3248950-snap-closes-below-ipo-open-amid-expanding-negative-sentiment?source=tweet\" data-url=\"https://seekingalpha.com/news/3248950-snap-closes-below-ipo-open-amid-expanding-negative-sentiment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>82&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248945\" data-ts=\"1488835421\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRML\" target=\"_blank\">VRML</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248945-vermillions-aspira-labs-secures-out-of-state-provider-status-california-medicaid-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vermillion&#39;s ASPiRA LABs secures out-of-state provider status with California Medicaid; shares; shares ahead 7% after hours</a></h4><ul><li>Thinly traded micro cap Vermillion (NASDAQ:<a href='https://seekingalpha.com/symbol/VRML' title='Vermillion, Inc.'>VRML</a>) is up&nbsp;<font color='green'>7%</font>&nbsp;after hours on light volume in response to its <a href=\"https://seekingalpha.com/pr/16762615-aspira-labs-announces-provider-status-medi-cal-expanding-ova1-access-12-million-beneficiaries\" target=\"_blank\">announcement </a>that subsidiary ASPiRA LABs has attained out-of-state provider status with Medi-Cal, California's Medicaid program, for its ovarian cancer risk assessment test OVA1/Multivariate Index Assay &#40;MIA&#41;. Medi-Cal has over 12M benefiiciaries.</li><li>CEO Valerie Palmieri says, \"We are pleased to announce our new Medi-Cal provider status for OVA1 &#40;MIA&#41;. This new status is an expansion to our prior Medi-Cal coverage and is key to reaching the entire Medicaid base, as well as expanding OVA1 &#40;MIA&#41; access in the state with the largest&nbsp;U.S.&nbsp;population. It should also create additional opportunities with healthcare systems and other medical insurers in the&nbsp;California&nbsp;market.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3248945\" data-linked=\"Vermillion&#39;s ASPiRA LABs secures out-of-state provider status with California Medicaid; shares; shares ahead 7% after hours\" data-tweet=\"$VRML - Vermillion&#39;s ASPiRA LABs secures out-of-state provider status with California Medicaid; shares; shares ahead 7% after hours https://seekingalpha.com/news/3248945-vermillions-aspira-labs-secures-out-of-state-provider-status-california-medicaid-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3248945-vermillions-aspira-labs-secures-out-of-state-provider-status-california-medicaid-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248927\" data-ts=\"1488834641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCRX\" target=\"_blank\">PCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248927-pacira-readies-300m-convertible-debt-offering-shares-off-9-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacira readies $300M convertible debt offering; shares off 9% after hours</a></h4><ul><li>Pacira Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a>) <a href=\"https://seekingalpha.com/pr/16762570-pacira-pharmaceuticals-announces-proposed-offering-300-million-aggregate-principal-amount\" target=\"_blank\">initiates </a>a direct offering of $300M aggregate principal amount of convertible senior notes due 2022 to qualified institutional investors. Price and terms have yet to be announced.</li><li>Shares are down&nbsp;<font color='red'>9%</font>&nbsp;after hours on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248927\" data-linked=\"Pacira readies $300M convertible debt offering; shares off 9% after hours\" data-tweet=\"$PCRX - Pacira readies $300M convertible debt offering; shares off 9% after hours https://seekingalpha.com/news/3248927-pacira-readies-300m-convertible-debt-offering-shares-off-9-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3248927-pacira-readies-300m-convertible-debt-offering-shares-off-9-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248916\" data-ts=\"1488834298\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DKS\" target=\"_blank\">DKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248916-favorable-reads-on-dicks-just-ahead-of-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Favorable reads on Dick&#39;s just ahead of earnings</a></h4><ul>     <li>Dick's Sporting Goods (NYSE:<a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a>) is <a href=\"https://www.wsj.com/articles/what-a-catch-dicks-sporting-goods-is-set-to-break-out-of-its-stock-slump-1488821776\" target=\"_blank\">undervalued</a>, according to the WSJ's Steven Russolillo</li>     <li>The retailer was swept up into a sector-wide sell-off tied to border tax fears and slow traffic trends, but has actually been showing improved margin and comp sales trends.</li>         <li>RBC also has a favorable read on Dick's, noting that the market is underappreciating the positive impact of consolidation in the sporting goods industry.</li><li>Dick's reports earnings tomorrow morning before the bell. Consensus estimates are for revenue of  $2.48, EPS of $1.30 and comparable sales growth of 4.5%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248916\" data-linked=\"Favorable reads on Dick&#39;s just ahead of earnings\" data-tweet=\"$DKS - Favorable reads on Dick&#39;s just ahead of earnings https://seekingalpha.com/news/3248916-favorable-reads-on-dicks-just-ahead-of-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3248916-favorable-reads-on-dicks-just-ahead-of-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248904\" data-ts=\"1488833072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KURA\" target=\"_blank\">KURA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248904-kuras-lead-candidate-tipifarnib-continues-to-demonstrate-treatment-benefit-in-mid-stage-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kura&#39;s lead candidate tipifarnib continues to demonstrate treatment benefit in mid-stage study; shares off 17% on profit taking</a></h4><ul><li>In an example of \"sell on the news,\" Kura Oncology (<a href='https://seekingalpha.com/symbol/KURA' title='Kura Oncology'>KURA</a> <font color='red'>-17%</font>) is experiencing profit-taking after last week's 60% run-up. The company <a href=\"https://seekingalpha.com/pr/16761624-kura-oncology-reports-updated-clinical-activity-data-ongoing-phase-2-trial-tipifarnib\" target=\"_blank\">announced </a>updated data from its ongoing Phase 2 clinical trial assessing lead product candidate tipifarnib in solid tumors today. The results were presented at the 15th International Congress on Targeted Anticancer Therapies in Paris.</li><li>Two responders with HRAS mutation-positive squamous cell carcinomas of the head and neck &#40;SCCHN&#41; remain on study at treatment cycle 19 and 12, respectively.</li><li>Three of five patients with HRAS-positive salivary gland cancer have stable disease through treatment cycles 9, 10 and 14, respectively.</li><li><a href=\"http://www.kuraoncology.com/pipeline/tipifarnib-hras/\" target=\"_blank\">Tipifarnib&nbsp;</a>inhibits an enzyme called farnesyl transferase. Interfering with its function inhibits protein farnesylation, a key signaling process in cancer initiation and development. Farnesyl transferase inhibitors have shown particular promise in blocking HRAS farnesylation.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3202325-kuras-lead-product-candidate-shows-encouraging-results-mid-stage-study-shares-32-percent\" target=\"_blank\">Kura's lead product candidate shows encouraging results in mid-stage study; shares up 32% after hours</a> (Aug. 10, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3248904\" data-linked=\"Kura&#39;s lead candidate tipifarnib continues to demonstrate treatment benefit in mid-stage study; shares off 17% on profit taking\" data-tweet=\"$KURA - Kura&#39;s lead candidate tipifarnib continues to demonstrate treatment benefit in mid-stage study; shares off 17% on profit taking https://seekingalpha.com/news/3248904-kuras-lead-candidate-tipifarnib-continues-to-demonstrate-treatment-benefit-in-mid-stage-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3248904-kuras-lead-candidate-tipifarnib-continues-to-demonstrate-treatment-benefit-in-mid-stage-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248899\" data-ts=\"1488831293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEM\" target=\"_blank\">NEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248899-newmont-gains-rights-to-explore-develop-prospective-new-yukon-gold-district\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Newmont gains rights to explore, develop prospective new Yukon gold district</a></h4><ul>     <li>Newmont Mining (<a href='https://seekingalpha.com/symbol/NEM' title='Newmont Mining Corporation &#40;Holding Company&#41;'>NEM</a> <font color='red'>-3.7%</font>) reaches an <a href=\"https://seekingalpha.com/pr/16762372-newmont-secures-rights-explore-develop-prospective-new-yukon-gold-district\" target=\"_blank\">agreement to access and explore</a> a highly prospective gold       district in Canada&rsquo;s Yukon Territory through a private placement with Goldstrike Resources that entitles NEM to earn up to 80% equity in the district through exploration investment.</li><li>NEM says initial drill results for the Plateau property are promising, and high grade gold mineralization  has been identified over a 50 km strike length.</li><li>NEM also says it expects to increase its exploration and advanced projects capex by 22% this year, with two-thirds used to fund more  brownfields and greenfields exploration.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248899\" data-linked=\"Newmont gains rights to explore, develop prospective new Yukon gold district\" data-tweet=\"$NEM - Newmont gains rights to explore, develop prospective new Yukon gold district https://seekingalpha.com/news/3248899-newmont-gains-rights-to-explore-develop-prospective-new-yukon-gold-district?source=tweet\" data-url=\"https://seekingalpha.com/news/3248899-newmont-gains-rights-to-explore-develop-prospective-new-yukon-gold-district\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248897\" data-ts=\"1488830447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248897-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/POLA' title='Polar Power Inc'>POLA</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/KONE' title='Kingtone Wirelessinfo Solution Holding Ltd'>KONE</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/MRIN' title='Marin Software'>MRIN</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/MATR' title='Mattersight Corporation'>MATR</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NH' title='NantHealth'>NH</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SUNW' title='Sunworks, Inc.'>SUNW</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248897\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$CCIH $POLA $KONE - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3248897-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3248897-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248895\" data-ts=\"1488830235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERN\" target=\"_blank\">ERN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248895-erin-energy-pacific-drilling-reach-drilling-deal-for-nigerian-offshore-field\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Erin Energy, Pacific Drilling reach drilling deal for Nigerian offshore field</a></h4><ul>     <li>Erin Energy (<a href='https://seekingalpha.com/symbol/ERN' title='Erin Energy Corp.'>ERN</a> <font color='green'>+1.4%</font>) announces a <a href=\"https://seekingalpha.com/pr/16761554-erin-energy-announces-execution-drilling-rig-contract\" target=\"_blank\">drilling services contract</a> with Pacific Drilling (<a href='https://seekingalpha.com/symbol/PACD' title='Pacific Drilling SA'>PACD</a> <font color='red'>-9.5%</font>) to use the <i>Pacific Bora</i> rig to drill the Oyo-9 well in the deepwater Oyo Field offshore Nigeria.</li>     <li>ERN says it has the option to drill up to two additional wells, and to extend the contract to drill two of its offshore Nigeria exploration prospects in the Miocene geological zone.</li><li>ERN anticipates spudding the  Oyo-9 in mid-June and first production from the well in September, and expects Oyo-9 to add 6K-7K bbl/day.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248895\" data-linked=\"Erin Energy, Pacific Drilling reach drilling deal for Nigerian offshore field\" data-tweet=\"$ERN $ERN $PACD - Erin Energy, Pacific Drilling reach drilling deal for Nigerian offshore field https://seekingalpha.com/news/3248895-erin-energy-pacific-drilling-reach-drilling-deal-for-nigerian-offshore-field?source=tweet\" data-url=\"https://seekingalpha.com/news/3248895-erin-energy-pacific-drilling-reach-drilling-deal-for-nigerian-offshore-field\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248892\" data-ts=\"1488828832\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248892-rh-moves-higher-on-takeover-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RH moves higher on takeover chatter</a></h4><ul> <li>RH (NYSE:<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a>) is rallying today after Betaville's Ben Harrington stirred up takeover speculation.</li> <li>Harrington mentioned the stock during an interview on TipTV (<a href=\"https://www.youtube.com/watch?v=q_rlK26lTt4\" target=\"_blank\">video</a>).</li> <li>Shares of RH are <font color='green'>up 2.53%</font> to $31.99 vs. a 52-week trading range of $24.41 to $46.87.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3248892\" data-linked=\"RH moves higher on takeover chatter\" data-tweet=\"$RH - RH moves higher on takeover chatter https://seekingalpha.com/news/3248892-rh-moves-higher-on-takeover-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3248892-rh-moves-higher-on-takeover-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248890\" data-ts=\"1488826904\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248890-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ESTE' title='Earthstone Energy, Inc.'>ESTE</a> <font color='green'>+7%</font>. URRE <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/TAT' title='TransAtlantic Petroleum Ltd.'>TAT</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy'>BCEI</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/PACD' title='Pacific Drilling SA'>PACD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/AAU' title='Almaden Minerals Ltd'>AAU</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248890\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$ESTE $WWR $TAT - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3248890-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3248890-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248880\" data-ts=\"1488824206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOS\" target=\"_blank\">BIOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248880-jefferies-boosts-price-target-on-bioscrip-shares-ahead-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies boosts price target on BioScrip; shares ahead 20%</a></h4><ul><li>BioScrip (<a href='https://seekingalpha.com/symbol/BIOS' title='BioScrip, Inc.'>BIOS</a> <font color='green'>+19.6%</font>) bucks the market's down day on more than a 4x surge in volume. This morning, Jefferies raised the price target 20% to $3 (36% upside) and reiterated its Buy rating.</li><li>Analyst Brian Tanquilut is \"incrementally positive\" on the stock after its Q4 beat citing good growth in core revenues that should offset the headwinds from the 21st Century Cures Act. He adds that EBITDA is on track to exceed $80M in 2018.</li><li>Source: StreetInsider</li></ul><div class=\"tiny-share-widget\" data-id=\"3248880\" data-linked=\"Jefferies boosts price target on BioScrip; shares ahead 20%\" data-tweet=\"$BIOS - Jefferies boosts price target on BioScrip; shares ahead 20% https://seekingalpha.com/news/3248880-jefferies-boosts-price-target-on-bioscrip-shares-ahead-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3248880-jefferies-boosts-price-target-on-bioscrip-shares-ahead-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248877\" data-ts=\"1488823251\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248877-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/ZAIS' title='ZAIS Group Holdings'>ZAIS</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/GLA' title='GlassBridge Enterprises, Inc.'>GLA</a> <font color='red'>-7%</font>. WMIH <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group'>PMTS</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248877\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$PN $ZAIS $GLA - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3248877-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3248877-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248879\" data-ts=\"1488823152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RRC\" target=\"_blank\">RRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248879-big-day-for-natural-gas-amid-cooler-weather-forecasts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big day for natural gas amid cooler weather forecasts</a></h4><ul>     <li><a href=\"https://www.wsj.com/articles/natural-gas-rallies-on-cooler-weather-forecasts-1488819394\" target=\"_blank\">Natural gas prices are rallying</a> today as recent weather forecasts favor cooler weather across much of the U.S., rising 3.7% to $2.931/MMBtu and extending a rebound that has sent prices higher for four straight trading sessions.</li>     <li>Nat gas prices had been held down by tepid demand amid one of the warmest winters on record, but forecasts now see temperatures falling below normal levels in the 6-10 day period and beyond.</li><li>Gas producers also may be getting a boost from a <a href=\"https://seekingalpha.com/news/3248687-barrons-range-resources-value\" target=\"_blank\">favorable review</a> in <em>Barron's</em> for Range Resources (<a href='https://seekingalpha.com/symbol/RRC' title='Range Resources Corporation'>RRC</a> <font color='green'>+4.7%</font>).</li><li>Also: <a href='https://seekingalpha.com/symbol/SWN' title='Southwestern Energy Co.'>SWN</a> <font color='green'>+3.1%</font>, <a href='https://seekingalpha.com/symbol/COG' title='Cabot Oil & Gas Corporation'>COG</a> <font color='green'>+2.8%</font>, <a href='https://seekingalpha.com/symbol/RICE' title='Rice Energy Inc'>RICE</a> <font color='green'>+4.1%</font>, <a href='https://seekingalpha.com/symbol/EQT' title='EQT Corporation'>EQT</a> <font color='green'>+1.8%</font>, <a href='https://seekingalpha.com/symbol/AR' title='Antero Resources Corporation'>AR</a> <font color='green'>+2.1%</font>, but <a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color='red'>-0.6%</font>.</li>     <li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GAZ-OLD' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ-OLD</a>, <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a>, <a href='https://seekingalpha.com/symbol/GASL' title='Direxion Daily Natural Gas Related Bull 3x Shares ETF'>GASL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>, <a href='https://seekingalpha.com/symbol/GASX' title='Direxion Daily Natural Gas Related Bear 3X Shares ETF'>GASX</a>, <a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3248879\" data-linked=\"Big day for natural gas amid cooler weather forecasts\" data-tweet=\"$RRC $RRC $SWN - Big day for natural gas amid cooler weather forecasts https://seekingalpha.com/news/3248879-big-day-for-natural-gas-amid-cooler-weather-forecasts?source=tweet\" data-url=\"https://seekingalpha.com/news/3248879-big-day-for-natural-gas-amid-cooler-weather-forecasts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248873\" data-ts=\"1488822984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTI\" target=\"_blank\">BTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248873-british-american-tobacco-seen-running-higher-off-rai-benefits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">British American Tobacco seen running higher off RAI benefits</a></h4><ul> <li>Argus Research <a href=\"https://www.streetinsider.com/Analyst+Comments/Argus+Upgrades+British+American+Tobacco+%28BTI%29+to+Buy/12632443.html\" target=\"_blank\">upgrades</a> British American Tobacco (<a href='https://seekingalpha.com/symbol/BTI' title='British American Tobacco p.l.c. &#40;American Depository Receipts&#41;'>BTI</a> <font color='red'>-0.4%</font>) to Buy from Hold with an eye on the Reynlds American acquisition.</li> <li>Argus on BTI:&nbsp;\"The acquisition, which is expected to close in 3Q17, will increase BTI's exposure to high-growth emerging markets while also strengthening its presence in the U.S. It will also help BTI to expand its R&amp;D program, which is focused on the of e-cigarettes and other smokeless products, and to boost its share of the smokeless market. Management plans to quadruple the number of markets in which it offers e-cigarettes and other smokeless products by 2018. We believe the near-term outlook for British American has improved and see further upside for the shares.\"</li> <li>The firm assigns a price target of $72 on the tobacco stock vs. a 52-week trading range of $52.71 to $65.67. The ADRs traded as high as $63.13 today.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3248873\" data-linked=\"British American Tobacco seen running higher off RAI benefits\" data-tweet=\"$BTI - British American Tobacco seen running higher off RAI benefits https://seekingalpha.com/news/3248873-british-american-tobacco-seen-running-higher-off-rai-benefits?source=tweet\" data-url=\"https://seekingalpha.com/news/3248873-british-american-tobacco-seen-running-higher-off-rai-benefits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248871\" data-ts=\"1488822742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248871-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TGTX' title='TG Therapeutics, Inc.'>TGTX</a> <font color='green'>+76%</font>. <a href='https://seekingalpha.com/symbol/CNCE' title='Concert Pharmaceuticals, Inc.'>CNCE</a> <font color='green'>+66%</font>. <a href='https://seekingalpha.com/symbol/DXTR' title='Dextera Surgical Inc.'>OTC:DXTR</a> <font color='green'>+49%</font>. <a href='https://seekingalpha.com/symbol/DPRX' title='Dipexium Pharmaceuticals, LLC'>DPRX</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/BIOS' title='BioScrip, Inc.'>BIOS</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='green'>+20%</font>. SPU <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/FLKS' title='Flex Pharma'>FLKS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/BLPH' title='Bellerophon Therapeutics'>BLPH</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/NH' title='NantHealth'>NH</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/SHLO' title='Shiloh Industries, Inc.'>SHLO</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/ATEC' title='Alphatec Holdings, Inc.'>ATEC</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/AFI' title='Armstrong Flooring, Inc.'>AFI</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/FCEL' title='FuelCell Energy, Inc.'>FCEL</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248871\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$TGTX $CNCE $DXTR - Midday Gainers / Losers https://seekingalpha.com/news/3248871-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3248871-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248869\" data-ts=\"1488822531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPM\" target=\"_blank\">WPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248869-silver-wheaton-willing-to-settle-canada-revenue-case-ceo-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Silver Wheaton willing to settle Canada Revenue case, CEO says</a></h4><ul><li>Silver Wheaton (SLW <font color='red'>-1.7%</font>) is willing to settle its <a href=\"https://seekingalpha.com/news/3039296-cra-audit-silver-wheaton-2011minus-13-tax-years\" target=\"_blank\">tax dispute</a> with the Canada Revenue Agency case for C$5M-C$10M  &ldquo;with gritted teeth&rdquo; but still believes no payment  should be required, CEO Randy Smallwood says.</li><li>The CEO says SLW is halfway through the discovery process, which he expects to end in middle of this year; any potential settlement likely would occur shortly after the discovery process but the company is willing to go to trial if a &ldquo;principled\" settlement is not possible.</li><li>Smallwood says the CRA issue is the most important &ldquo;catalyst&rdquo; for SLW stock, which he says is paying too high a price for the uncertainty.</li><li>Source: Bloomberg First Word</li></ul><div class=\"tiny-share-widget\" data-id=\"3248869\" data-linked=\"Silver Wheaton willing to settle Canada Revenue case, CEO says\" data-tweet=\"$WPM - Silver Wheaton willing to settle Canada Revenue case, CEO says https://seekingalpha.com/news/3248869-silver-wheaton-willing-to-settle-canada-revenue-case-ceo-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3248869-silver-wheaton-willing-to-settle-canada-revenue-case-ceo-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248863\" data-ts=\"1488821122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORR\" target=\"_blank\">CORR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248863-corenergy-trust-downgraded-stifel-on-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CorEnergy Trust downgraded at Stifel on valuation</a></h4><ul>     <li>CorEnergy Infrastructure Trust (<a href='https://seekingalpha.com/symbol/CORR' title='CorEnergy Infrastructure Trust'>CORR</a> <font color='red'>-4.4%</font>) is <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Stifel+Downgrades+CorEnergy+Infrastructure+Trust+%28CORR%29+to+Hold/12632186.html\" target=\"_blank\">downgraded</a> to Hold from Buy with a $34 price target, trimmed from $37, at Stifel, after posting a solid quarter with AFFO of $13.9M and DPU coverage of 1.5x on a <a href=\"https://seekingalpha.com/news/3248066-corenergy-provides-3-share-dividend-guidance\" target=\"_blank\">flat $0.75 quarterly distribution</a>.</li><li>CORR notes that Ultra Petroleum remains in bankruptcy, although a confirmation hearing  is set and it hopes Ultra will soon emerge from the process; subsequently, Stifel says CORR should receive incremental credit facility capacity with an eye on growing its asset base again.</li>     <li>The firm says it maintains a favorable view of CORR's niche structure and management's deal structuring history, but it believes shares are near fair value.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248863\" data-linked=\"CorEnergy Trust downgraded at Stifel on valuation\" data-tweet=\"$CORR - CorEnergy Trust downgraded at Stifel on valuation https://seekingalpha.com/news/3248863-corenergy-trust-downgraded-stifel-on-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3248863-corenergy-trust-downgraded-stifel-on-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248861\" data-ts=\"1488820638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CETV\" target=\"_blank\">CETV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248861-central-european-media-cuts-borrowing-cost-150-basis-points\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Central European Media cuts borrowing cost by 150 basis points</a></h4><ul>   <li>Central European Media (NASDAQ:<a href='https://seekingalpha.com/symbol/CETV' title='Central European Media Enterprises Ltd.'>CETV</a>) is <font color='green'>up 3.4%</font> after a transaction with Time Warner that will <a href=\"https://seekingalpha.com/pr/16761608-central-european-media-enterprises-announces-debt-repricing-immediately-reduces-average\" target=\"_blank\">cut its average borrowing cost</a> on debt by 150 basis points.</li>    <li>The deal is effective as of March 1, 2017, and involves fees payable to Time Warner in its capacity as guarantor of CETV's senior credit.</li>    <li>It reduces the cost of borrowing on a &euro;251M term loan due 2018 by 125 basis points, and gets a similar rate reduction on a &euro;235M term loan due 2019. It also cuts the borrowing cost of a &euro;469M term loan due 2021 by 175 basis points.</li>    <li>In all, the weighted average borrowing cost drops to 7.25%.</li>    <li>The cost of borrowing will drop a further 50 basis points if the total indebtedness in senior credit facilities is reduced below &euro;815M by Sept. 30, 2018.</li>    <li>The move is expected to result in $30M in savings from debt service by the end of next year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248861\" data-linked=\"Central European Media cuts borrowing cost by 150 basis points\" data-tweet=\"$CETV - Central European Media cuts borrowing cost by 150 basis points https://seekingalpha.com/news/3248861-central-european-media-cuts-borrowing-cost-150-basis-points?source=tweet\" data-url=\"https://seekingalpha.com/news/3248861-central-european-media-cuts-borrowing-cost-150-basis-points\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248857\" data-ts=\"1488819816\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKRX\" target=\"_blank\">AKRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248857-deutsche-bank-cuts-outlook-on-akorn-on-erosion-of-ephedrine-line-shares-ease-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank cuts outlook on Akorn on erosion of ephedrine line; shares ease 7%</a></h4><ul><li>The market's down day notwithstanding, Akorn (<a href='https://seekingalpha.com/symbol/AKRX' title='Akorn, Inc.'>AKRX</a> <font color='red'>-7%</font>) is under pressure after Deutsche Bank downgraded the stock to Hold and cut the price target to $24 (6% upside) from $28.</li><li>Analyst Gregg Gilbert says he likes the large number of ANDA's (marketing applications for generic products) under review at the FDA, but share erosion for its ultra-high-margin ephedrine line, representing almost 20% of revenue, is a significant headwind.</li><li>Source: <a href=\"https://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Downgrades+Akorn+%28AKRX%29+to+Hold/12632000.html\" target=\"_blank\">StreetInsider</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3248857\" data-linked=\"Deutsche Bank cuts outlook on Akorn on erosion of ephedrine line; shares ease 7%\" data-tweet=\"$AKRX - Deutsche Bank cuts outlook on Akorn on erosion of ephedrine line; shares ease 7% https://seekingalpha.com/news/3248857-deutsche-bank-cuts-outlook-on-akorn-on-erosion-of-ephedrine-line-shares-ease-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3248857-deutsche-bank-cuts-outlook-on-akorn-on-erosion-of-ephedrine-line-shares-ease-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248856\" data-ts=\"1488819668\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248856-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> SPU <font color='green'>+20%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/OTIV' title='On Track Innovations Ltd'>OTIV</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/REV' title='Revlon, Inc.'>REV</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/STKL' title='SunOpta, Inc.'>STKL</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248856\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$FTFT $GPRO $OTIV - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3248856-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3248856-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248847\" data-ts=\"1488819029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NH\" target=\"_blank\">NH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248847-nanthealth-slips-15-on-alleged-self-dealing-patrick-soon-shiong-and-university-of-utah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NantHealth slips 15% on alleged self-dealing between Patrick Soon-Shiong and University of Utah</a></h4><ul><li>NantHealth (<a href='https://seekingalpha.com/symbol/NH' title='NantHealth'>NH</a> <font color='red'>-14.8%</font>) a Patrick Soon-Shiong-controlled provider of a molecular test for cancer, called <a href=\"http://www.gpscancer.com/\" target=\"_blank\">GPS Cancer</a>, is under pressure on double normal volume, albeit on turnover of only 290K shares, on a <a href=\"https://www.statnews.com/2017/03/06/soon-shiong-philanthropy-business/\" target=\"_blank\">STAT report</a> about a $12M gift by the billionaire in September 2014 to the University of Utah that appeared to direct the bulk of the money ($10M) back to his company.</li><li>The deal enabled NantHealth to inflate the number of test orders it received for GPS Cancer by more than 50% when it updated investors during its Q3 earnings call in November on the demand for the test. It stated that it had received 524 orders for GPS Cancer, including 1/3 from the University of Utah. A spokesperson from the university and a geneticist who works there said the work they ordered had nothing to do with GPS Cancer, however. It was straightforward genetic sequencing associated with preclinical research.</li><li>Dr. Soon-Shiong has yet to comment on the matter.</li><li><strong>Update</strong>: On March 16, NantHealth and Dr. Soon-Shiong <a href=\"https://seekingalpha.com/pr/16773916-nanthealth-dr-soon-shiong-send-letters-statnews-com-listing-errors-corresponding-facts\" target=\"_blank\">issued written rebuttals</a> to STAT's assertions.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248847\" data-linked=\"NantHealth slips 15% on alleged self-dealing between Patrick Soon-Shiong and University of Utah\" data-tweet=\"$NH - NantHealth slips 15% on alleged self-dealing between Patrick Soon-Shiong and University of Utah https://seekingalpha.com/news/3248847-nanthealth-slips-15-on-alleged-self-dealing-patrick-soon-shiong-and-university-of-utah?source=tweet\" data-url=\"https://seekingalpha.com/news/3248847-nanthealth-slips-15-on-alleged-self-dealing-patrick-soon-shiong-and-university-of-utah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248848\" data-ts=\"1488818019\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLCO\" target=\"_blank\">MLCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248848-melco-crown-and-sjm-bosses-see-big-jump-in-macau-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Melco Crown and SJM bosses see big jump in Macau revenue</a></h4><ul> <li>Melco Crown Entertainment (MPEL <font color='red'>-0.8%</font>) Chairman Lawrence Ho <a href=\"https://www.ggrasia.com/sjm-mpel-bosses-flag-positive-2017-macau-ggr-trend/\" target=\"_blank\">expects</a> Macau gaming revenue to increase 5% to 9% this year across the industry.</li> <li>Looking at Melco, Ho thinks the mass market business will benefit in the back half after the Hong Kong-Zuhai-Macau bridge is finished.</li> <li>SJM Holdings (<a href='https://seekingalpha.com/symbol/SJMHF' title='SJM Holdings Ltd.'>OTCPK:SJMHF</a>, <a href='https://seekingalpha.com/symbol/SJMHY' title='SJM Holdings Ltd. ADR'>OTCPK:SJMHY</a>) boss Ambrose So Shu Fai sees gaming revenue increasing 10% for the year.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3248848\" data-linked=\"Melco Crown and SJM bosses see big jump in Macau revenue\" data-tweet=\"$MLCO $MLCO $SJMHF - Melco Crown and SJM bosses see big jump in Macau revenue https://seekingalpha.com/news/3248848-melco-crown-and-sjm-bosses-see-big-jump-in-macau-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3248848-melco-crown-and-sjm-bosses-see-big-jump-in-macau-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248844\" data-ts=\"1488816883\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEM\" target=\"_blank\">AEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248844-agnico-eagle-mines-to-buy-38_1m-shares-of-goldquest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agnico Eagle Mines to buy 38.1M shares of GoldQuest</a></h4><ul><li>Agnico Eagle Mines (<a href='https://seekingalpha.com/symbol/AEM' title='Agnico Eagle Mines Limited'>AEM</a> <font color='red'>-2.1%</font>) says it <a href=\"https://seekingalpha.com/pr/16761790-agnico-eagle-announces-investment-goldquest-mining-corp\" target=\"_blank\">will buy 38.1M shares</a> of GoldQuest Mining (<a href='https://seekingalpha.com/symbol/GDQMF' title='Goldquest Mining Corp.'>OTCPK:GDQMF</a> <font color='green'>+14.3%</font>) shares at C$0.60 each for C$22.9M through a non-brokered private placement, which will make AEM the largest holder of GoldQuest with ~15% stake.</li><li>AEM will have the right to nominate one person to GoldQuest's board and participate in future equity financings.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248844\" data-linked=\"Agnico Eagle Mines to buy 38.1M shares of GoldQuest\" data-tweet=\"$AEM $AEM $GDQMF - Agnico Eagle Mines to buy 38.1M shares of GoldQuest https://seekingalpha.com/news/3248844-agnico-eagle-mines-to-buy-38_1m-shares-of-goldquest?source=tweet\" data-url=\"https://seekingalpha.com/news/3248844-agnico-eagle-mines-to-buy-38_1m-shares-of-goldquest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248841\" data-ts=\"1488816425\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIE\" target=\"_blank\">CIE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248841-cobalt-energyminus-5-delays-release-of-q4-fy-2016-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cobalt Energy -5% as it delays release of Q4, FY 2016 results</a></h4><ul>     <li>Cobalt Energy (<a href='https://seekingalpha.com/symbol/CIE' title='Cobalt International Energy, Inc.'>CIE</a> <font color='red'>-4.3%</font>) is lower after announcing a <a href=\"https://seekingalpha.com/pr/16761602-cobalt-international-energy-inc-reschedules-earnings-call-incorporate-preliminary-north\" target=\"_blank\">delay</a> in releasing its Q4 and year-end 2016 financial results to Mar. 14 from Mar. 8.</li>     <li>CIE says it needs more time to complete operations on the North Platte #4 sidetrack well and provide a more comprehensive update.</li><li>CIE said <a href=\"https://seekingalpha.com/news/3247694-cobalt-energy-gets-nyse-continued-listing-standard-notice\" target=\"_blank\">last week</a> it received a continued listing standard notice from the NYSE after shares averaged less than $1 for the preceding 30-day period.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248841\" data-linked=\"Cobalt Energy -5% as it delays release of Q4, FY 2016 results\" data-tweet=\"$CIE - Cobalt Energy -5% as it delays release of Q4, FY 2016 results https://seekingalpha.com/news/3248841-cobalt-energyminus-5-delays-release-of-q4-fy-2016-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3248841-cobalt-energyminus-5-delays-release-of-q4-fy-2016-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248839\" data-ts=\"1488816007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248839-healthcare-top-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TGTX' title='TG Therapeutics, Inc.'>TGTX</a> <font color='green'>+90%</font>. <a href='https://seekingalpha.com/symbol/CNCE' title='Concert Pharmaceuticals, Inc.'>CNCE</a> <font color='green'>+81%</font>. <a href='https://seekingalpha.com/symbol/DXTR' title='Dextera Surgical Inc.'>OTC:DXTR</a> <font color='green'>+62%</font>. <a href='https://seekingalpha.com/symbol/VBIV' title='VBI Vaccines'>VBIV</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/BIOS' title='BioScrip, Inc.'>BIOS</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/AKRX' title='Akorn, Inc.'>AKRX</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CALA' title='Calithera Biosciences'>CALA</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ADAP' title='Adaptimmune Therapeutics plc'>ADAP</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248839\" data-linked=\"Healthcare - Top Gainers / Losers as of 11:00 am\" data-tweet=\"$TGTX $CNCE $DXTR - Healthcare - Top Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3248839-healthcare-top-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3248839-healthcare-top-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248837\" data-ts=\"1488815923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248837-vale-s-new-ceo-to-be-chosen-in-late-march-early-april-minister-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vale\u2019s new CEO to be chosen in late March or early April, minister says</a></h4><ul>     <li>A decision on who will replace Vale (<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='red'>-2.4%</font>) CEO Murilo Ferreira, whose contract <a href=\"https://seekingalpha.com/news/3246366-vale-ceo-ferreira-leave-contract-expires-may\" target=\"_blank\">will not be renewed</a> when it expires on May 26, could come by the <a href=\"http://www.reuters.com/article/us-mining-pdac-brazil-idUSKBN16C0YC\" target=\"_blank\">end of March or beginning of April</a>, Brazil Energy  Minister Fernando Coelho Filho tells Reuters.</li>     <li>The minister says government pension funds will have a key role in the selection process, along with other partners in Vale.</li>     <li>Coelho also says bills to reform Brazil&rsquo;s mining industry should go before  the country's congress in late March or early April and could be enacted by 110 days  after that.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248837\" data-linked=\"Vale\u2019s new CEO to be chosen in late March or early April, minister says\" data-tweet=\"$VALE - Vale\u2019s new CEO to be chosen in late March or early April, minister says https://seekingalpha.com/news/3248837-vale-s-new-ceo-to-be-chosen-in-late-march-early-april-minister-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3248837-vale-s-new-ceo-to-be-chosen-in-late-march-early-april-minister-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248836\" data-ts=\"1488815394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GM\" target=\"_blank\">GM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248836-gm-investors-sell-opel-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GM investors sell the Opel news</a></h4><ul> <li>General Motors (NYSE:<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a>) is lower after announcing its monster deal to sell off Opel.</li> <li>The company also disclosed today that it will lay off 1,100 workers in May at a Lansing plant as production shifts to Tennessee.</li> <li>Nomura Instinet is one of the first investment firms to weigh in on the GM Opel decision. The firm <a href=\"http://99wallstreet.com/ratings/stock/GM/\" target=\"_blank\">lifts</a> GM to a Buy rating on its view that the simplified business will be easier to manage and share buybacks will be ramped up.</li> <li>Shares of GM are <font color='red'>down 2.22%</font> to $37.38</li><li>Previously: <a href=\"https://seekingalpha.com/news/3248697-general-motors-sells-opel-2_2b\" target=\"_blank\">General Motors sells Opel for &euro;2.2B</a> (March 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248836\" data-linked=\"GM investors sell the Opel news\" data-tweet=\"$GM - GM investors sell the Opel news https://seekingalpha.com/news/3248836-gm-investors-sell-opel-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3248836-gm-investors-sell-opel-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248835\" data-ts=\"1488815085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CETX\" target=\"_blank\">CETX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248835-cemtrexminus-15-on-report-of-factory-closing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cemtrex -15% on report of factory closing</a></h4><ul><li>In an Instablog post on Seeking Alpha, <a href=\"https://seekingalpha.com/instablog/6460311-unemon1/4965971-cemtrex-cetx-rob-cemtrex-close-paderborn-factory-disaster-game\" target=\"_blank\">Unemon1 takes note </a>of German media stories from last week reporting Cemtrex (<a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a> <font color='red'>-15.5%</font>) is expected to close its Paderborn plant by the end of October.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3245366-cemtrex-minus-37-percent-threatens-legal-action-misleading-article\" target=\"_blank\">Cemtrex -37%; threatens legal action over misleading article</a> (Feb. 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3248835\" data-linked=\"Cemtrex -15% on report of factory closing\" data-tweet=\"$CETX - Cemtrex -15% on report of factory closing https://seekingalpha.com/news/3248835-cemtrexminus-15-on-report-of-factory-closing?source=tweet\" data-url=\"https://seekingalpha.com/news/3248835-cemtrexminus-15-on-report-of-factory-closing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248834\" data-ts=\"1488814868\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CALM\" target=\"_blank\">CALM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248834-south-korea-u-s-poultry-ban-to-impact-calm-and-post\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">South Korea U.S. poultry ban to impact CALM and POST</a></h4><ul> <li>A ban of poultry imports from the U.S. will impact Cal-Maine Foods (<a href='https://seekingalpha.com/symbol/CALM' title='Cal-Maine Foods, Inc.'>CALM</a> <font color='red'>-0.8%</font>) most directly, warns Goldman Sachs.</li> <li>Post Holdings (<a href='https://seekingalpha.com/symbol/POST' title='Post Holdings, Inc.'>POST</a> <font color='red'>-1.8%</font>) is expected to see a \"modest\" negative effect through its Michael's property, according to the firm.</li> <li>South Korea banned U.S. poultry after the first confirmed case this year of the highly pathogenic H7 avian influenza was reported at a Tyson-contracted farm in Tennessee.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3248768-tyson-alert-bird-flu-case-tennessee\" target=\"_blank\">Tyson on alert after bird flu case in Tennessee</a> (March 6)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3248813-avian-flu-case-sends-safm-ppc-lower\" target=\"_blank\">Avian flu case sends SAFM and PPC lower</a> (March 6)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3248834\" data-linked=\"South Korea U.S. poultry ban to impact CALM and POST\" data-tweet=\"$CALM $CALM $POST - South Korea U.S. poultry ban to impact CALM and POST https://seekingalpha.com/news/3248834-south-korea-u-s-poultry-ban-to-impact-calm-and-post?source=tweet\" data-url=\"https://seekingalpha.com/news/3248834-south-korea-u-s-poultry-ban-to-impact-calm-and-post\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248833\" data-ts=\"1488814813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GURE\" target=\"_blank\">GURE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248833-gulf-resourcesplus-2-on-strong-outlook-for-bromine-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gulf Resources +2% on strong outlook for bromine business</a></h4><ul><li>Gulf Resources (<a href='https://seekingalpha.com/symbol/GURE' title='GULF RESOURCES INC'>GURE</a> <font color='green'>+2.1%</font>) rises after announcing that continuing strength in the price of  bromine should lead to <a href=\"https://seekingalpha.com/pr/16761849-gulf-resources-sees-continuing-strength-bromine-business\" target=\"_blank\">significantly improved sales and earnings</a> in  bromine business, especially in H1 2017.</li><li>GURE says the price of bromine has continued to increase since the end of Q3 2016, and was +17% Y/Y to $4,142/metric ton at the beginning of March.</li><li>GURE will provide guidance when it releases financial results later this month, but says it  has good visibility for H1 and expects increases in sales and earnings for  bromine business.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248833\" data-linked=\"Gulf Resources +2% on strong outlook for bromine business\" data-tweet=\"$GURE - Gulf Resources +2% on strong outlook for bromine business https://seekingalpha.com/news/3248833-gulf-resourcesplus-2-on-strong-outlook-for-bromine-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3248833-gulf-resourcesplus-2-on-strong-outlook-for-bromine-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248827\" data-ts=\"1488814758\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DXTR\" target=\"_blank\">DXTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248827-dexteras-stapling-platform-reduces-hospital-stay-in-patients-undergoing-microlobectomy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dextera&#39;s stapling platform reduces hospital stay in patients undergoing microlobectomy procedures; shares jump 38%</a></h4><ul><li>Thinly traded nano cap <a href=\"https://www.dexterasurgical.com/\" target=\"_blank\">Dextera Surgical</a> (<a href='https://seekingalpha.com/symbol/DXTR' title='Dextera Surgical Inc.'>OTC:DXTR</a> <font color='green'>+37.7%</font>) heads north on a 6x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/16761834-dextera-surgical-s-microcutter-5-80-enables-shorter-hospital-stays-less-invasive-lobectomy\" target=\"_blank\">announcement </a>of positive data related to the use of its articulating surgical stapling platform in 82 patients undergoing microlobectomy (removal of a lobe of a lung via a small hole through the abdomen). The results were presented at the Scandinavian Society for Research in Cardiothoracic Surgery.</li><li>The data showed that the use of the company's MicroCutter 5/80 surgical stapler reduced postoperative pain and complications compared to traditional open procedures and reduced median hospital stay by at least two days. A fifth (20%) of the patients were able to be discharged the day after surgery.</li><li>The <a href=\"https://www.dexterasurgical.com/microcutter-580/\" target=\"_blank\">MicroCutter 5/80</a> Stapler is manufactured and cleared for use in&nbsp;the United States&nbsp;for transection and resection in multiple open or minimally invasive urologic, thoracic and pediatric surgical procedures, as well as other applications.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248827\" data-linked=\"Dextera&#39;s stapling platform reduces hospital stay in patients undergoing microlobectomy procedures; shares jump 38%\" data-tweet=\"$DXTR - Dextera&#39;s stapling platform reduces hospital stay in patients undergoing microlobectomy procedures; shares jump 38% https://seekingalpha.com/news/3248827-dexteras-stapling-platform-reduces-hospital-stay-in-patients-undergoing-microlobectomy?source=tweet\" data-url=\"https://seekingalpha.com/news/3248827-dexteras-stapling-platform-reduces-hospital-stay-in-patients-undergoing-microlobectomy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248831\" data-ts=\"1488814629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRP\" target=\"_blank\">FRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248831-fairpointminus-1_6-q4-profits-miss-amid-revenue-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FairPoint -1.6% as Q4 profits miss amid revenue decline</a></h4><ul>   <li>FairPoint Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/FRP' title='FairPoint Communications, Inc.'>FRP</a>) has <font color='red'>fallen 1.6%</font> in early going after it posted mixed <a href=\"https://seekingalpha.com/news/3248712-fairpoint-communications-misses-0_41-beats-revenue\" target=\"_blank\">Q4 earnings</a> where revenues declined slightly but beat expectations, and net income slid.</li>    <li>Net profit fell to $16M from $40.2M; EBITDA grew by $1M to $64.9M, beating an expected $62.2M.</li>    <li>Revenue breakout: Voice services, $71.5M (down 7.6%); Access, $58.2M (down 6.2%); Data and Internet services, $49.1M (up 9.3%); Regulatory funding, $12.5M (down 5%); Other services, $12.6M (up 2.4%).</li>    <li>It's guiding to 2017 unlevered free cash flow of $105M-$115M, capex of $110M-$115M and EBITDA of $245M-$250M (vs. consensus for $247.9M).</li>    <li>It won't hold a call due to its planned merger with Consolidated Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/CNSL' title='Consolidated Communications Holdings, Inc.'>CNSL</a>); the two companies have special meetings set for March 28 to get shareholder approvals, with a targeted closing in mid-2017.</li>    <li><a href=\"https://seekingalpha.com/pr/16761497-fairpoint-communications-reports-2016-fourth-quarter-full-year-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3248831\" data-linked=\"FairPoint -1.6% as Q4 profits miss amid revenue decline\" data-tweet=\"$FRP $FRP $CNSL - FairPoint -1.6% as Q4 profits miss amid revenue decline https://seekingalpha.com/news/3248831-fairpointminus-1_6-q4-profits-miss-amid-revenue-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/3248831-fairpointminus-1_6-q4-profits-miss-amid-revenue-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248830\" data-ts=\"1488814626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTR\" target=\"_blank\">VTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248830-brookdale-seniorminus-5-ventas-says-not-in-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brookdale Senior -5%; Ventas says not in talks</a></h4><ul><li>Presenting at the Citi Global Property Conference, Ventas (<a href='https://seekingalpha.com/symbol/VTR' title='Ventas Inc.'>VTR</a> <font color='red'>-0.9%</font>) says it's not currently in talks to purchase Brookdale Senior Living (<a href='https://seekingalpha.com/symbol/BKD' title='Brookdale Senior Living Inc.'>BKD</a> <font color='red'>-4.9%</font>).</li><li><a href=\"http://www.ventasreit.com/sites/default/files/corporate_presentations/Investor_Presentation_Citi-2017-March-Conference_vF.PDF\" target=\"_blank\">Presentation slides</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3244167-ventas-talks-buy-brookdale-senior-dj\" target=\"_blank\">Ventas in talks to buy Brookdale Senior - DJ</a> (Feb. 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3248830\" data-linked=\"Brookdale Senior -5%; Ventas says not in talks\" data-tweet=\"$VTR $VTR $BKD - Brookdale Senior -5%; Ventas says not in talks https://seekingalpha.com/news/3248830-brookdale-seniorminus-5-ventas-says-not-in-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3248830-brookdale-seniorminus-5-ventas-says-not-in-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248819\" data-ts=\"1488813245\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248819-ionis-pharmas-volanesorsen-successful-in-late-stage-study-in-rare-inherited-enzyme-disorder\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ionis Pharma&#39;s volanesorsen successful in late-stage study in rare inherited enzyme disorder; effect on platelet counts weighs on shares, down 7%</a></h4><ul><li>Ionis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='red'>-6.9%</font>) is down despite its <a href=\"https://seekingalpha.com/pr/16761618-akcea-ionis-announce-positive-results-pivotal-study-volanesorsen-patients-familial\" target=\"_blank\">announcement </a>of successful results in a Phase 3 clinical trial, APPROACH, evaluating subsidiary Akcea Therapeutics' volanesorsen in lowering triglyceride levels in patients with <a href=\"http://fcs.raredr.com/\" target=\"_blank\">familial chylomicronemia syndrome </a>&#40;FCS&#41;, a rare inherited enzyme disorder that results in excessive levels of triglycerides in the plasma.</li><li>The study met its primary endpoint but a treatment-related side effect is apparently concerning investors. Specifically, declines in platelet counts associated with decreases in triglycerides were observed in many patients. Five subjects discontinued treatment due to the side effect. The company adds that three patients experienced grade 4 (life-threatening) thrombocytopenia which resolved with cessation of dosing.</li><li><a href=\"https://www.isispharm.com/pipeline/\" target=\"_blank\">Volanesorsen&nbsp;</a>is an antisense drug designed to reduce the production of ApoC-III, a protein produced by the liver that regulates triglyceride metabolism.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248819\" data-linked=\"Ionis Pharma&#39;s volanesorsen successful in late-stage study in rare inherited enzyme disorder; effect on platelet counts weighs on shares, down 7%\" data-tweet=\"$IONS - Ionis Pharma&#39;s volanesorsen successful in late-stage study in rare inherited enzyme disorder; effect on platelet counts weighs on shares, down 7% https://seekingalpha.com/news/3248819-ionis-pharmas-volanesorsen-successful-in-late-stage-study-in-rare-inherited-enzyme-disorder?source=tweet\" data-url=\"https://seekingalpha.com/news/3248819-ionis-pharmas-volanesorsen-successful-in-late-stage-study-in-rare-inherited-enzyme-disorder\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248824\" data-ts=\"1488812960\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRGI\" target=\"_blank\">FRGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248824-insider-buying-action-propels-fiesta-restaurant-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Insider buying action propels Fiesta Restaurant Group</a></h4><ul> <li>Fiesta Restaurant Group (<a href='https://seekingalpha.com/symbol/FRGI' title='Fiesta Restaurant Group, Inc.'>FRGI</a> <font color='green'>+4.3%</font>) board member Brain Paul Friedman picked upp 660K shares between March 1 and March 3.</li> <li>The shares were picked up in a range of $19.83 to $20.68.</li> <li><a href=\"https://seekingalpha.com/symbol/FRGI/key-data/filings\" target=\"_blank\">Fiesta SEC filings</a></li> <li>Previously: <a href=\"https://seekingalpha.com/news/3248793-fiesta-restaurant-group-looks-recover\" target=\"_blank\">Fiesta Restaurant Group looks to recover</a> (March 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248824\" data-linked=\"Insider buying action propels Fiesta Restaurant Group\" data-tweet=\"$FRGI - Insider buying action propels Fiesta Restaurant Group https://seekingalpha.com/news/3248824-insider-buying-action-propels-fiesta-restaurant-group?source=tweet\" data-url=\"https://seekingalpha.com/news/3248824-insider-buying-action-propels-fiesta-restaurant-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248813\" data-ts=\"1488811896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAFM\" target=\"_blank\">SAFM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248813-avian-flu-case-sends-safm-and-ppc-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avian flu case sends SAFM and PPC lower</a></h4><ul> <li>Shares of Sanderson Farms (<a href='https://seekingalpha.com/symbol/SAFM' title='Sanderson Farms, Inc.'>SAFM</a> <font color='red'>-2.5%</font>) and Pilgrim's Pride (<a href='https://seekingalpha.com/symbol/PPC' title='Pilgrim&#39;s Pride Corporation'>PPC</a> <font color='red'>-1.8%</font>) are lower after the first confirmed case of the highly pathogenic H7 avian influenza this year occurred at a Tyson-contracted farm in Tennessee.</li> <li>Tyson is reportedly working with state and federal officials to contain the virus, while Pilgrim's Pride says it's activated a biosecurity response plan.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3248768-tyson-alert-bird-flu-case-tennessee\" target=\"_blank\">Tyson on alert after bird flu case in Tennessee</a> (March 6)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3248813\" data-linked=\"Avian flu case sends SAFM and PPC lower\" data-tweet=\"$SAFM $SAFM $PPC - Avian flu case sends SAFM and PPC lower https://seekingalpha.com/news/3248813-avian-flu-case-sends-safm-and-ppc-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3248813-avian-flu-case-sends-safm-and-ppc-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248809\" data-ts=\"1488811215\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248809-delta-guidance-rattles-airline-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delta guidance rattles airline sector</a></h4><ul>     <li>Delta Air Lines (<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a> <font color='red'>-1.8%</font>) rattles the airline sector with some fresh guidance issued at the Raymond James 38th Annual Institutional Investors Conference.</li>     <li>The company expects Q1 operating margin of 10% to 11% vs. a prior forecast of 11% to 13%.</li>     <li>Costs increases are expected to run ahead of revenue growth this year, according to Delta.</li>     <li>Passenger revenue per available seat mile is now seen as coming in flat for the quarter, down from a prior forecast for a range of flat to +2%.</li>     <li>Delta on margins: \" Margins under pressure in 1H17, but we are focused on returning to margin expansion in the back half of the year as improving RASM trajectory catches up to cost increases.\"</li>     <li><a href=\"http://s1.q4cdn.com/231238688/files/Conferences/2017/Delta-Air-Lines-Raymond-James-38th-Annual.pdf\" target=\"_blank\">Delta presentation slides</a> (.pdf)</li>     <li>Other airline stocks moving in reaction to Delta's guidance include American Airlines Group (<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group'>AAL</a> <font color='red'>-2.2%</font>), United Continental (<a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc'>UAL</a> <font color='red'>-3%</font>), Southwest Airlines (<a href='https://seekingalpha.com/symbol/LUV' title='Southwest Airlines Co.'>LUV</a> <font color='red'>-1.7%</font>) and JetBlue (<a href='https://seekingalpha.com/symbol/JBLU' title='JetBlue Airways Corporation'>JBLU</a> <font color='red'>-2.1%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248809\" data-linked=\"Delta guidance rattles airline sector\" data-tweet=\"$DAL $DAL $AAL - Delta guidance rattles airline sector https://seekingalpha.com/news/3248809-delta-guidance-rattles-airline-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3248809-delta-guidance-rattles-airline-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248800\" data-ts=\"1488810367\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSCO\" target=\"_blank\">TSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248800-tractor-supply-makes-guggenheim-best-ideas-list\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tractor Supply makes the Guggenheim Best Ideas List</a></h4><ul> <li>Tractor Supply (NASDAQ:<a href='https://seekingalpha.com/symbol/TSCO' title='Tractor Supply Company'>TSCO</a>) is added to the \"Best Ideas List\" at Guggenheim Securities.</li> <li>The company recently set FY17 revenue guidance ahead of expectations.</li> <li>Shares of Tractor Supply are <font color='green'>up 0.15%</font> premarket to $72.50.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3248800\" data-linked=\"Tractor Supply makes the Guggenheim Best Ideas List\" data-tweet=\"$TSCO - Tractor Supply makes the Guggenheim Best Ideas List https://seekingalpha.com/news/3248800-tractor-supply-makes-guggenheim-best-ideas-list?source=tweet\" data-url=\"https://seekingalpha.com/news/3248800-tractor-supply-makes-guggenheim-best-ideas-list\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248795\" data-ts=\"1488809850\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248795-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TGTX' title='TG Therapeutics, Inc.'>TGTX</a> <font color='green'>+79%</font>. <a href='https://seekingalpha.com/symbol/CNCE' title='Concert Pharmaceuticals, Inc.'>CNCE</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/POLA' title='Polar Power Inc'>POLA</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/RNVA' title='Rennova Health, Inc.'>OTCPK:RNVA</a> <font color='green'>+18%</font>.<b> </b><a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/IMUC' title='ImmunoCellular Therapeutics, Ltd.'>OTCPK:IMUC</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/NOVN' title='Novan'>NOVN</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis Inc.'>ADXS</a> <font color='green'>+8%</font>.<b> </b><a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/XGTI' title='xG Technology, Inc.'>XGTI</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/RRC' title='Range Resources Corporation'>RRC</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248795\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$TGTX $CNCE $POLA - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3248795-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3248795-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248793\" data-ts=\"1488809614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRGI\" target=\"_blank\">FRGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248793-fiesta-restaurant-group-looks-to-recover\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fiesta Restaurant Group looks to recover</a></h4><ul> <li>Shares of Fiesta Restaurant Group (NASDAQ:<a href='https://seekingalpha.com/symbol/FRGI' title='Fiesta Restaurant Group, Inc.'>FRGI</a>) are <font color='green'>up 6.57%</font> to $21.10 on moderate volume.</li> <li>The restaurant stock sank last week after the company disclosed that it's not going to pursue a sale.</li><li>Costs of sales have improved recently for Fiesta on lower commodity expenses.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3246838-fiesta-restaurant-eps-line-misses-revenue\" target=\"_blank\">Fiesta Restaurant EPS in-line, misses on revenue</a> (Feb. 27)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3246845-fiesta-restaurant-hires-ceo-decides-sale-14-percent\" target=\"_blank\">Fiesta Restaurant hires CEO, decides on no sale; down 14%</a> (Feb. 27)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3248793\" data-linked=\"Fiesta Restaurant Group looks to recover\" data-tweet=\"$FRGI - Fiesta Restaurant Group looks to recover https://seekingalpha.com/news/3248793-fiesta-restaurant-group-looks-to-recover?source=tweet\" data-url=\"https://seekingalpha.com/news/3248793-fiesta-restaurant-group-looks-to-recover\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248792\" data-ts=\"1488809353\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORT\" target=\"_blank\">CORT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248792-corcept-therapeutics-eps-and-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corcept Therapeutics EPS and revenue in-line</a></h4><ul><li>Corcept Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CORT' title='Corcept Therapeutics Incorporated'>CORT</a>): Q4 EPS of $0.04 in-line.</li><li>Revenue of $23.81M (+59.1% Y/Y) in-line.</li><li>Shares <font color='green'>+1.64%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16761846-corcept-therapeutics-announces-fourth-quarter-full-year-2016-financial-results-increases-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3248792\" data-linked=\"Corcept Therapeutics EPS and revenue in-line\" data-tweet=\"$CORT - Corcept Therapeutics EPS and revenue in-line https://seekingalpha.com/news/3248792-corcept-therapeutics-eps-and-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3248792-corcept-therapeutics-eps-and-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248791\" data-ts=\"1488809299\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMUC\" target=\"_blank\">IMUC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248791-immunocellular-amends-protocol-of-late-state-study-of-lead-product-candidate-to-allow-for\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmunoCellular amends protocol of late-state study of lead product candidate to allow for faster randomization; shares ahead 17% premarket</a></h4><ul><li>Thinly traded nano cap ImmunoCellular Therapeutics (<a href='https://seekingalpha.com/symbol/IMUC' title='ImmunoCellular Therapeutics, Ltd.'>OTCPK:IMUC</a>) is up&nbsp;<font color='green'>17%&nbsp;</font>premarket on modestly higher volume in response to its <a href=\"https://seekingalpha.com/pr/16761474-immunocellular-therapeutics-provides-update-ictminus-107-phase-3-glioblastoma-trial-announces\" target=\"_blank\">announcement</a> that the FDA has approved its request to modify the protocol in its <a href=\"https://clinicaltrials.gov/ct2/show/NCT02546102?term=ict-107&amp;phase=2&amp;rank=1\" target=\"_blank\">Phase 3 clinical trial</a> assessing lead product candidate ICT-107 in newly diagnosed glioblastoma. The key change will allow patients to be randomized 30 days after the start of screening procedures, accelerating the time to randomization by ~two months. Currently, the estimated final data collection date for the primary endpoint of overall survival is December 2019.</li><li><a href=\"http://www.imuc.com/pipeline/ict-107\" target=\"_blank\">ICT-107</a>&nbsp;is an autologous dendritic cell immunotherapeutic that targets six different antigens associated with glioblastoma. It is designed for use following surgical tumor resection of newly diagnosed glioblastoma in combination with radiotherapy and chemotherapy.</li><li>The company also announces the successful completion of the first milestone for its Stem-to-T-cell program, the sequencing of a selected T cell receptor &#40;TCR&#41; gene. When placed into a blood stem cell, the TCR gene should enhance the immune system to produce killer T cells to attack tumor cells.</li><li>Management will provide more details on both developments later this month during the Q4 conference call.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248791\" data-linked=\"ImmunoCellular amends protocol of late-state study of lead product candidate to allow for faster randomization; shares ahead 17% premarket\" data-tweet=\"$IMUC - ImmunoCellular amends protocol of late-state study of lead product candidate to allow for faster randomization; shares ahead 17% premarket https://seekingalpha.com/news/3248791-immunocellular-amends-protocol-of-late-state-study-of-lead-product-candidate-to-allow-for?source=tweet\" data-url=\"https://seekingalpha.com/news/3248791-immunocellular-amends-protocol-of-late-state-study-of-lead-product-candidate-to-allow-for\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248788\" data-ts=\"1488809115\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRYS\" target=\"_blank\">DRYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248788-dryships-exercises-vlgc-option\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DryShips exercises VLGC option</a></h4><ul> <li>DryShips Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a>)&nbsp;announced that it exercised an option to acquire up to four Very Large Gas Carriers currently under construction at Hyundai Heavy Industries Co. for a purchase price of $83.5M.</li><li>The VLGCs have a time charter attached to an oil major.</li><li>Approximately 25% of the purchase price will be paid on closing, with the balance payable in installments until the vessel's delivery from HHI.</li><li>DryShips expects the total gross backlog associated with this time charter to be $54.0M, or $92.7M including the optional periods.</li><li>The first deliveries are expected in September of this year.</li>  <li>DRYS  <font color='red'>-3.65%</font> premarket to  $1.32.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16761921-dryships-exercises-second-option-acquire-large-gas-carrier-5-year-time-charter-attached-oil\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3248788\" data-linked=\"DryShips exercises VLGC option\" data-tweet=\"$DRYS - DryShips exercises VLGC option https://seekingalpha.com/news/3248788-dryships-exercises-vlgc-option?source=tweet\" data-url=\"https://seekingalpha.com/news/3248788-dryships-exercises-vlgc-option\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248785\" data-ts=\"1488808867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPLP\" target=\"_blank\">SPLP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248785-steel-partners-offers-29-per-share-for-rest-of-handy-harman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steel Partners offers $29 per share for rest of Handy &amp; Harman</a></h4><ul><li>Steel Partners (NYSE:<a href='https://seekingalpha.com/symbol/SPLP' title='Steel Partners Holdings L.P.'>SPLP</a>) currently owns about 70% of Handy &amp; Harman (NASDAQ:<a href='https://seekingalpha.com/symbol/HNH' title='Handy & Harman Ltd.'>HNH</a>). <a href=\"https://seekingalpha.com/pr/16761907-steel-partners-holdings-l-p-makes-proposal-acquire-remaining-shares-handy-and-harman-ltd\" target=\"_blank\">It's offering $29</a> per share in cash for the remainder of the company.</li><li>That would be a&nbsp;<font color='green'>4.3% premium&nbsp;</font>to Friday's close.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248785\" data-linked=\"Steel Partners offers $29 per share for rest of Handy &amp; Harman\" data-tweet=\"$SPLP $SPLP $HNH - Steel Partners offers $29 per share for rest of Handy &amp; Harman https://seekingalpha.com/news/3248785-steel-partners-offers-29-per-share-for-rest-of-handy-harman?source=tweet\" data-url=\"https://seekingalpha.com/news/3248785-steel-partners-offers-29-per-share-for-rest-of-handy-harman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248779\" data-ts=\"1488808389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AA\" target=\"_blank\">AA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248779-alcoa-upgraded-to-buy-goldman-sachs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcoa upgraded to Buy at Goldman Sachs</a></h4><ul>     <li>Alcoa (NYSE:<a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a>) <font color='green'>+1.5%</font> premarket as Goldman Sachs <a href=\"http://thefly.com/landingPageNews.php?id=2515372&amp;headline=AA-Alcoa-upgraded-to-Buy-from-Neutral-at-Goldma\" target=\"_blank\">upgrades shares to Buy</a> from Neutral and raises its six-month  price target $52 from $34, TheFly.com reports.</li><li>Goldman says China's capacity cuts are improving  industry dynamics, and the firm expects  AA to generate a 12% free cash yield on average through 2018 amid  higher aluminum and alumina prices.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248779\" data-linked=\"Alcoa upgraded to Buy at Goldman Sachs\" data-tweet=\"$AA - Alcoa upgraded to Buy at Goldman Sachs https://seekingalpha.com/news/3248779-alcoa-upgraded-to-buy-goldman-sachs?source=tweet\" data-url=\"https://seekingalpha.com/news/3248779-alcoa-upgraded-to-buy-goldman-sachs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248777\" data-ts=\"1488808255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADXS\" target=\"_blank\">ADXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248777-fda-oks-advaxis-ind-for-personalized-cancer-immunotherapy-candidate-adxs-neo-shares-ahead-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Advaxis&#39; IND for personalized cancer immunotherapy candidate ADXS-NEO; shares ahead 10% premarket</a></h4><ul><li>Advaxis (NASDAQ:<a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis Inc.'>ADXS</a>) perks up&nbsp;<font color='green'>10%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/16761496-advaxis-announces-fda-acceptance-ind-groundbreaking-personalized-neoepitope-immunotherapy\" target=\"_blank\">announcement </a>that the FDA has approved its Investigational New Drug &#40;IND&#41; application for ADXS-NEO, a personalized neoantigen-targeted cancer immunotherapy that it is developing with Amgen (NASDAQ:<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a>).</li><li>The agency's blessing on the IND clears the way for the start of clinical trials. A Phase 1 in multiple tumor types will be initiated later this year.</li><li>ADXS-NEO utilizes Advaxis' <em>Listeria monocytogenes</em> ((<em>Lm</em>))-based antigen delivery technology to target multiple patient-specific neoantigens in each individual patient's tumor that are not present in normal cells. It is designed to stimulate both the innate and adaptive arms of the immune system.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248777\" data-linked=\"FDA OKs Advaxis&#39; IND for personalized cancer immunotherapy candidate ADXS-NEO; shares ahead 10% premarket\" data-tweet=\"$ADXS $ADXS $AMGN - FDA OKs Advaxis&#39; IND for personalized cancer immunotherapy candidate ADXS-NEO; shares ahead 10% premarket https://seekingalpha.com/news/3248777-fda-oks-advaxis-ind-for-personalized-cancer-immunotherapy-candidate-adxs-neo-shares-ahead-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3248777-fda-oks-advaxis-ind-for-personalized-cancer-immunotherapy-candidate-adxs-neo-shares-ahead-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248775\" data-ts=\"1488807332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTCT\" target=\"_blank\">PTCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248775-fda-to-review-ptcs-marketing-application-for-dmd-candidate-translarna-under-protest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA to review PTC&#39;s marketing application for DMD candidate Translarna under protest regulations; action date October 24; shares ahead 15% premarket</a></h4><ul><li>PTC Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a>) is up&nbsp;<font color='green'>15%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16761719-ptc-therapeutics-announces-fda-acknowledgment-new-drug-application-filing-translarna\" target=\"_blank\">announcement </a>that the FDA has acknowledged the filing of protest of its New Drug Application &#40;NDA&#41; seeking approval of Translarna (ataluren) for the treatment of Duchenne muscular dystrophy &#40;DMD&#41;. The agency's action date &#40;PDUFA&#41; is October 24.</li><li>The FDA rejected its original NDA filing in October 2016 under \"Refuse to File\" &nbsp;which means that the application was not complete enough to allow for review. File over protest regulations allow a company to have its NDA filed and reviewed following receipt of a Refuse to File letter.</li><li>Related ticker: (NASDAQ:<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3214284-ptc-therapeutics-hoping-follow-sareptas-path-fda-review-dmd-candidate-translarna-gets\" target=\"_blank\">PTC Therapeutics hoping to follow Sarepta's path with FDA review of DMD candidate Translarna but gets rejected, appeal planned; shares down 21% premarket</a> (Oct. 17, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3248775\" data-linked=\"FDA to review PTC&#39;s marketing application for DMD candidate Translarna under protest regulations; action date October 24; shares ahead 15% premarket\" data-tweet=\"$PTCT $PTCT $SRPT - FDA to review PTC&#39;s marketing application for DMD candidate Translarna under protest regulations; action date October 24; shares ahead 15% premarket https://seekingalpha.com/news/3248775-fda-to-review-ptcs-marketing-application-for-dmd-candidate-translarna-under-protest?source=tweet\" data-url=\"https://seekingalpha.com/news/3248775-fda-to-review-ptcs-marketing-application-for-dmd-candidate-translarna-under-protest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248772\" data-ts=\"1488807082\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MVIS\" target=\"_blank\">MVIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248772-microvisionplus-19-pre-market-q4-2016-mixed-significant-growth-expected-for-2017\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MicroVision +19% pre-market; Q4 2016 mixed, &#39;significant growth&#39; expected for 2017</a></h4><ul>     <li><strong><a href=\"https://seekingalpha.com/news/3248758-microvision-misses-0_01-beats-revenue\" target=\"_blank\">&nbsp;Q4 2016 results</a></strong> &ndash; revenue $2.91M (+57.3% Y/Y,&nbsp;<font color='green'>$0.21M above estimates</font>), EPS -$0.09 (<font color='red'>$0.01 below estimates</font>), operating loss $5.3M (vs. $4.3M operating loss Y/Y), net loss $5.4M (vs. $4.3M net loss Y/Y)</li><li>Planned LBS engines business revenue is anticipated at $30M-$60M within the 12-18 months subsequent initial mass production shipment expected in Q2 2017. Revenue contribution from the segment is projected for weighting in H2 2017. Further anticipates additional delivery of proof-of-concept ADAS demonstrator to a \"major technology company\" within the year.</li><li><strong>Pre-market</strong> &ndash; (NASDAQ:<a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a>) $1.93</li><li><a href=\"https://seekingalpha.com/pr/16761707-microvision-announces-2016-financial-operating-results-annual-revenue-grew-60-percent\" target=\"_blank\">Press release</a> / <a href=\"http://edge.media-server.com/m/p/jspkff8p/lan/en\" target=\"_blank\">conference call</a> / <a href=\"https://seekingalpha.com/filing/3446363\" target=\"_blank\">8-K</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3248772\" data-linked=\"MicroVision +19% pre-market; Q4 2016 mixed, &#39;significant growth&#39; expected for 2017\" data-tweet=\"$MVIS - MicroVision +19% pre-market; Q4 2016 mixed, &#39;significant growth&#39; expected for 2017 https://seekingalpha.com/news/3248772-microvisionplus-19-pre-market-q4-2016-mixed-significant-growth-expected-for-2017?source=tweet\" data-url=\"https://seekingalpha.com/news/3248772-microvisionplus-19-pre-market-q4-2016-mixed-significant-growth-expected-for-2017\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248768\" data-ts=\"1488806642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSN\" target=\"_blank\">TSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248768-tyson-on-alert-after-bird-flu-case-in-tennessee\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyson on alert after bird flu case in Tennessee</a></h4><ul> <li>Shares of Tyson Foods (NYSE:<a href='https://seekingalpha.com/symbol/TSN' title='Tyson Foods Inc.'>TSN</a>) are on watch after the USDA <a href=\"http://www.reuters.com/article/us-health-birdflu-usa-idUSKBN16C0XL\" target=\"_blank\">confirmed</a> a case of avian influenza at a Tyson-contracted farm in Tennessee.</li> <li>It's the first confirmed case of the highly pathogenic H7 avian influenza this year.</li> <li>Over 73K birds at the farm will be euthanized in order to stop the HPAI bird flu from spreading.</li> <li>Shares of Tyson are <font color='red'>down 2.67%</font> premarket to $61.90.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248768\" data-linked=\"Tyson on alert after bird flu case in Tennessee\" data-tweet=\"$TSN - Tyson on alert after bird flu case in Tennessee https://seekingalpha.com/news/3248768-tyson-on-alert-after-bird-flu-case-in-tennessee?source=tweet\" data-url=\"https://seekingalpha.com/news/3248768-tyson-on-alert-after-bird-flu-case-in-tennessee\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248766\" data-ts=\"1488806278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOVN\" target=\"_blank\">NOVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248766-novan-to-move-ahead-sb204-development-nda-filing-targeted-in-q1-2018-shares-up-12-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novan to move ahead with SB204 development, NDA filing targeted in Q1 2018; shares up 12% premarket</a></h4><ul><li>Novan (NASDAQ:<a href='https://seekingalpha.com/symbol/NOVN' title='Novan'>NOVN</a>) perks up&nbsp;<font color='green'>12%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16761505-novan-provides-update-sb204-development-program\" target=\"_blank\">announcement </a>that it will proceed with the development acne candidate SB204. Its decision was based on an internal assessment of the clinical trial data and input from consultants. Shares plummeted in January after one of two Phase 3 trials failed to meet all of its efficacy endpoints.</li><li>The company says it will seek a pre-submission meeting with the FDA in Q3 and expects to file a New Drug Application &#40;NDA&#41; in Q1 2018.</li><li>SB204 is a topical gel based on the company's&nbsp;<a href=\"http://www.novantherapeutics.com/technology/controlled-release/\" target=\"_blank\">NITRICIL&nbsp;</a>technology which enables the timed release of&nbsp;<a href=\"http://www.nutritionexpress.com/showarticle.aspx?articleid=286\" target=\"_blank\">nitric oxide</a>, a molecule that regulates inflammation and boosts the immune system, among other effects.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3238404-novans-lead-product-product-shows-mixed-results-pivotal-studies-shares-plummet-76-percent\" target=\"_blank\">Novan's lead product product shows mixed results in pivotal studies; shares plummet 76%</a> (Jan. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3248766\" data-linked=\"Novan to move ahead with SB204 development, NDA filing targeted in Q1 2018; shares up 12% premarket\" data-tweet=\"$NOVN - Novan to move ahead with SB204 development, NDA filing targeted in Q1 2018; shares up 12% premarket https://seekingalpha.com/news/3248766-novan-to-move-ahead-sb204-development-nda-filing-targeted-in-q1-2018-shares-up-12-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3248766-novan-to-move-ahead-sb204-development-nda-filing-targeted-in-q1-2018-shares-up-12-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248760\" data-ts=\"1488805479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGTX\" target=\"_blank\">TGTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248760-tg-therapeuticss-blood-cancer-candidate-ublituximab-successful-in-late-state-study-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TG Therapeutics&#39;s blood cancer candidate ublituximab successful in late-state study; shares jump 53% premarket</a></h4><ul><li>TG Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/TGTX' title='TG Therapeutics, Inc.'>TGTX</a>) is up&nbsp;<font color='green'>53%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16761570-tg-therapeutics-announces-positive-topline-data-phase-3-genuine-study-tgminus-1101\" target=\"_blank\">announcement </a>of positive results from a Phase 3 clinical trial,<a href=\"https://clinicaltrials.gov/ct2/show/NCT02301156?term=NCT02301156&amp;rank=1\" target=\"_blank\">GENUINE</a>, assessing TG-1101 (ublituximab) plus ibrutinib [AbbVie's (NYSE:<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>) Imbruvica] in treatment-experienced high-risk chronic lymphocytic leukemia &#40;CLL&#41; patients.</li><li>The study met its primary endpoint of overall response rate &#40;ORR&#41; compared to ibrutinib alone in both the intent-to-treat population (p=0.001) and treated population (p&lt;0.001). Specifically, in the treated population, the ORR was 80% for TG-1101 plus ibrutinib versus 47% for ibrutinib alone.</li><li>A complete analysis of the data will be submitted for presentation at an upcoming medical conference. The company plans to meet with the FDA as soon as possible afterward to discuss an application for accelerated approval.</li><li>TG-1101 is a glycoengineered anti-CD20 monoclonal antibody.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248760\" data-linked=\"TG Therapeutics&#39;s blood cancer candidate ublituximab successful in late-state study; shares jump 53% premarket\" data-tweet=\"$TGTX $TGTX $ABBV - TG Therapeutics&#39;s blood cancer candidate ublituximab successful in late-state study; shares jump 53% premarket https://seekingalpha.com/news/3248760-tg-therapeuticss-blood-cancer-candidate-ublituximab-successful-in-late-state-study-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3248760-tg-therapeuticss-blood-cancer-candidate-ublituximab-successful-in-late-state-study-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248758\" data-ts=\"1488805334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MVIS\" target=\"_blank\">MVIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248758-microvision-misses-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microvision misses by $0.01, beats on revenue</a></h4><ul><li>Microvision (NASDAQ:<a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a>): Q4 EPS of -$0.09 <font color='red'>misses by $0.01</font>.</li><li>Revenue of $2.91M (+57.3% Y/Y) <font color='green'>beats by $0.21M</font>.</li><li>Shares <font color='green'>+11.1%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16761707-microvision-announces-2016-financial-operating-results-annual-revenue-grew-60-percent'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3248758\" data-linked=\"Microvision misses by $0.01, beats on revenue\" data-tweet=\"$MVIS - Microvision misses by $0.01, beats on revenue https://seekingalpha.com/news/3248758-microvision-misses-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3248758-microvision-misses-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248751\" data-ts=\"1488804630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRO\" target=\"_blank\">GPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248751-goprominus-3-after-goldman-cuts-to-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GoPro -3% after Goldman cuts to Sell</a></h4><ul><li>GoPro (NASDAQ:<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a>) faces \"significant challenges\" with saturation of the action camera market, product rollout issues in the holiday season, and disappointing entry into drones, says analyst Simona Jankowski, downgrading to Sell with $6 price target (vs. Friday's $8.84 close).</li><li>Shares&nbsp;<font color='red'>-3.2%</font>&nbsp;premarket to $8.56.</li><li>This is GoPro's 2nd Sell rating in two sessions. Shares were<font color='red'> lower by 4.6%</font>&nbsp;on Friday <a href=\"https://seekingalpha.com/news/3248449-gopro-minus-1_5-percent-citi-starts-coverage-sell\" target=\"_blank\">after Citi initiated</a> coverage with a Sell.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248751\" data-linked=\"GoPro -3% after Goldman cuts to Sell\" data-tweet=\"$GPRO - GoPro -3% after Goldman cuts to Sell https://seekingalpha.com/news/3248751-goprominus-3-after-goldman-cuts-to-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/3248751-goprominus-3-after-goldman-cuts-to-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248748\" data-ts=\"1488804258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248748-snap-gets-barrons-treatment-and-another-sell-side-sell-call-still-up-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap gets Barron&#39;s treatment, and another sell-side sell call; still up 4% premarket</a></h4><ul><li>A weekend article <a href=\"http://www.barrons.com/articles/snaps-stock-price-could-be-cut-in-half-1488609430?mod=BOL_hp_highlight_3\" target=\"_blank\">by <em>Barron's</em> Andrew Bary</a> says there's 50% downside in <a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>.</li><li>This morning, Needham's Laura Martin <a href=\"https://www.streetinsider.com/Analyst+Comments/Needham+%26+Company+Starts+Snap+Inc+%28SNAP%29+at+Underperform/12632423.html\" target=\"_blank\">initiates coverage with an Underperform</a> rating, and $19-$23 price target range (vs. Friday's $27.09 close). \"Sometimes lottery tickets pay off,\" she says, but there are plenty of risks with Snap.</li><li>1) Snap's total addressable market is 80% smaller than Facebook's 2) Snap already has 50% penetration of said total addressable market in the U.S. 3) Her $3.3B revenue estimate in 2019 assumes Snap has a 14-16% share of adjusted digital ad spend then vs. 2% today 4) Even if revenue does grow to that, the share price would decline based on EV/sales ratios for Facebook and Google 5) No clear path to profitability 6) Academic literature suggests poor year one performance.</li><li>Shares&nbsp;<font color='green'>+3.9%</font>&nbsp;premarket to $28.10.</li></ul><div class=\"tiny-share-widget\" data-id=\"3248748\" data-linked=\"Snap gets Barron&#39;s treatment, and another sell-side sell call; still up 4% premarket\" data-tweet=\"$SNAP - Snap gets Barron&#39;s treatment, and another sell-side sell call; still up 4% premarket https://seekingalpha.com/news/3248748-snap-gets-barrons-treatment-and-another-sell-side-sell-call-still-up-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3248748-snap-gets-barrons-treatment-and-another-sell-side-sell-call-still-up-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248732\" data-ts=\"1488802771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XRX\" target=\"_blank\">XRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248732-xerox-on-move-after-barrons-mention\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xerox on the move after Barron&#39;s mention</a></h4><ul> <li>A favorable mention in <a href=\"http://www.barrons.com/articles/xerox-hits-the-restart-button-1488606625\" target=\"_blank\">Barron's</a> sends Xerox (NYSE:<a href='https://seekingalpha.com/symbol/XRX' title='Xerox Corporation'>XRX</a>) higher in early trading.</li> <li>The lush dividend yield at Xerox and the increased focus by management on cost-cutting are seen as attractive.</li> <li>A portfolio manager for ValueWorks sees shares of Xerox almost doubling to hit $14 in two years amid the favorable climate.</li> <li>XRX <font color='green'>+2.85%</font> premarket to $7.57.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248732\" data-linked=\"Xerox on the move after Barron&#39;s mention\" data-tweet=\"$XRX - Xerox on the move after Barron&#39;s mention https://seekingalpha.com/news/3248732-xerox-on-move-after-barrons-mention?source=tweet\" data-url=\"https://seekingalpha.com/news/3248732-xerox-on-move-after-barrons-mention\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3248729\" data-ts=\"1488802276\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3248729-ubs-sees-breakout-for-netflix\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS sees breakout for Netflix</a></h4><ul> <li>Shares of Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) are on watch after UBS calls out strong Q1 global subscriber growth for the company.</li> <li>The investment firm bases its forecast off of app download data.</li> <li>UBS takes Netflix to a Buy rating from Neutral and lifts the price target to $175 from $136.</li><li>Source: Bloomberg</li> <li>NFLX <font color='green'>+1.88%</font> premarket to $141.75.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3248729\" data-linked=\"UBS sees breakout for Netflix\" data-tweet=\"$NFLX - UBS sees breakout for Netflix https://seekingalpha.com/news/3248729-ubs-sees-breakout-for-netflix?source=tweet\" data-url=\"https://seekingalpha.com/news/3248729-ubs-sees-breakout-for-netflix\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":64,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}